ASCENTAGE PHARMA GRP INTERNATIONAL

HKEX: 6855 (ASCENTAGE-B)

Last update: 22 May, 9:59AM

48.75

-0.45 (-0.91%)

Previous Close 49.20
Open 48.90
Volume 3,803,438
Avg. Volume (3M) 4,286,564
Market Cap 16,986,888,192
Price / Sales 21.81
Price / Book 86.39
52 Weeks Range
16.94 (-65%) — 52.65 (7%)
Earnings Date 27 Mar 2025
Profit Margin -41.34%
Operating Margin (TTM) -361.23%
Diluted EPS (TTM) -1.46
Quarterly Revenue Growth (YOY) 97.90%
Total Debt/Equity (MRQ) 608.58%
Current Ratio (MRQ) 1.26
Operating Cash Flow (TTM) -111.36 M
Levered Free Cash Flow (TTM) -81.25 M
Return on Assets (TTM) -9.25%
Return on Equity (TTM) -235.32%

Market Trend

Short Term Medium Term
Industry Biotechnology (HK) Mixed Mixed
Biotechnology (Global) Bearish Bearish
Stock ASCENTAGE-B - -

AIStockmoo Score

1.5
Analyst Consensus 0.0
Insider Activity NA
Price Volatility 1.0
Technical Moving Averages 1.0
Technical Oscillators 4.0
Average 1.50

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ASCENTAGE-B 17 B - - 86.39
BEIGENE 221 B - - 8.31
INNOCARE 30 B - - 3.19
HENLIUS 24 B - 26.46 8.48
EVEREST MED 19 B - - 3.78
INNOVENT BIO 126 B - - 8.83

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.

Sector Healthcare
Industry Biotechnology
Investment Style Mid Growth
% Held by Insiders 24.40%
% Held by Institutions 13.22%

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria